mTOR inhibition, AKT proteins and chronic kidney disease
Inhibición de mTOR, proteínas AKT y enfermedad renal crónica
Read
18716
Timeswas read the article
5417
Total PDF
13299
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 180 | 219 | 399 |
| 2025 5 | 118 | 33 | 151 |
| 2025 4 | 107 | 24 | 131 |
| 2025 3 | 122 | 67 | 189 |
| 2025 2 | 103 | 34 | 137 |
| 2025 1 | 69 | 44 | 113 |
| 2024 12 | 71 | 31 | 102 |
| 2024 11 | 72 | 37 | 109 |
| 2024 10 | 70 | 31 | 101 |
| 2024 9 | 57 | 30 | 87 |
| 2024 8 | 66 | 56 | 122 |
| 2024 7 | 55 | 28 | 83 |
| 2024 6 | 77 | 42 | 119 |
| 2024 5 | 90 | 44 | 134 |
| 2024 4 | 74 | 36 | 110 |
| 2024 3 | 62 | 2254 | 2316 |
| 2024 2 | 59 | 41 | 100 |
| 2024 1 | 54 | 24 | 78 |
| 2023 12 | 72 | 29 | 101 |
| 2023 11 | 78 | 45 | 123 |
| 2023 10 | 164 | 46 | 210 |
| 2023 9 | 328 | 26 | 354 |
| 2023 8 | 244 | 27 | 271 |
| 2023 7 | 85 | 29 | 114 |
| 2023 6 | 143 | 23 | 166 |
| 2023 5 | 98 | 35 | 133 |
| 2023 4 | 51 | 18 | 69 |
| 2023 3 | 55 | 22 | 77 |
| 2023 2 | 57 | 20 | 77 |
| 2023 1 | 38 | 31 | 69 |
| 2022 12 | 66 | 28 | 94 |
| 2022 11 | 66 | 31 | 97 |
| 2022 10 | 61 | 51 | 112 |
| 2022 9 | 52 | 33 | 85 |
| 2022 8 | 70 | 48 | 118 |
| 2022 7 | 48 | 49 | 97 |
| 2022 6 | 62 | 44 | 106 |
| 2022 5 | 88 | 29 | 117 |
| 2022 4 | 70 | 53 | 123 |
| 2022 3 | 70 | 48 | 118 |
| 2022 2 | 87 | 53 | 140 |
| 2022 1 | 86 | 33 | 119 |
| 2021 12 | 75 | 40 | 115 |
| 2021 11 | 81 | 31 | 112 |
| 2021 10 | 108 | 49 | 157 |
| 2021 9 | 66 | 43 | 109 |
| 2021 8 | 92 | 37 | 129 |
| 2021 7 | 69 | 37 | 106 |
| 2021 6 | 66 | 30 | 96 |
| 2021 5 | 76 | 48 | 124 |
| 2021 4 | 149 | 85 | 234 |
| 2021 3 | 126 | 47 | 173 |
| 2021 2 | 110 | 31 | 141 |
| 2021 1 | 71 | 15 | 86 |
| 2020 12 | 79 | 22 | 101 |
| 2020 11 | 78 | 18 | 96 |
| 2020 10 | 45 | 21 | 66 |
| 2020 9 | 64 | 15 | 79 |
| 2020 8 | 66 | 14 | 80 |
| 2020 7 | 76 | 22 | 98 |
| 2020 6 | 66 | 28 | 94 |
| 2020 5 | 86 | 17 | 103 |
| 2020 4 | 73 | 29 | 102 |
| 2020 3 | 74 | 16 | 90 |
| 2020 2 | 67 | 20 | 87 |
| 2020 1 | 70 | 19 | 89 |
| 2019 12 | 92 | 22 | 114 |
| 2019 11 | 59 | 19 | 78 |
| 2019 10 | 58 | 18 | 76 |
| 2019 9 | 56 | 15 | 71 |
| 2019 8 | 54 | 27 | 81 |
| 2019 7 | 74 | 12 | 86 |
| 2019 6 | 85 | 25 | 110 |
| 2019 5 | 64 | 19 | 83 |
| 2019 4 | 121 | 34 | 155 |
| 2019 3 | 82 | 35 | 117 |
| 2019 2 | 43 | 25 | 68 |
| 2019 1 | 59 | 28 | 87 |
| 2018 12 | 155 | 61 | 216 |
| 2018 11 | 146 | 21 | 167 |
| 2018 10 | 122 | 20 | 142 |
| 2018 9 | 176 | 21 | 197 |
| 2018 8 | 99 | 15 | 114 |
| 2018 7 | 79 | 20 | 99 |
| 2018 6 | 95 | 21 | 116 |
| 2018 5 | 91 | 15 | 106 |
| 2018 4 | 108 | 16 | 124 |
| 2018 3 | 78 | 9 | 87 |
| 2018 2 | 64 | 13 | 77 |
| 2018 1 | 94 | 10 | 104 |
| 2017 12 | 87 | 10 | 97 |
| 2017 11 | 85 | 19 | 104 |
| 2017 10 | 94 | 12 | 106 |
| 2017 9 | 61 | 15 | 76 |
| 2017 8 | 73 | 13 | 86 |
| 2017 7 | 79 | 12 | 91 |
| 2017 6 | 75 | 13 | 88 |
| 2017 5 | 110 | 19 | 129 |
| 2017 4 | 100 | 20 | 120 |
| 2017 3 | 78 | 15 | 93 |
| 2017 2 | 198 | 11 | 209 |
| 2017 1 | 58 | 10 | 68 |
| 2016 12 | 111 | 10 | 121 |
| 2016 11 | 130 | 15 | 145 |
| 2016 10 | 211 | 20 | 231 |
| 2016 9 | 335 | 9 | 344 |
| 2016 8 | 382 | 4 | 386 |
| 2016 7 | 318 | 9 | 327 |
| 2016 6 | 253 | 0 | 253 |
| 2016 5 | 228 | 0 | 228 |
| 2016 4 | 261 | 0 | 261 |
| 2016 3 | 210 | 0 | 210 |
| 2016 2 | 290 | 0 | 290 |
| 2016 1 | 201 | 0 | 201 |
| 2015 12 | 184 | 0 | 184 |
| 2015 11 | 202 | 0 | 202 |
| 2015 10 | 210 | 0 | 210 |
| 2015 9 | 165 | 0 | 165 |
| 2015 8 | 161 | 0 | 161 |
| 2015 7 | 178 | 0 | 178 |
| 2015 6 | 119 | 0 | 119 |
| 2015 5 | 175 | 0 | 175 |
| 2015 4 | 45 | 0 | 45 |
Show all
